Albany, NY, August 26, 2008 – Institute for Clinical Pharmacodynamics (ICPD) today announced that Dr. Paul G. Ambrose, Pharm.D., FIDSA will present at an American Academy of Veterinary Pharmacology and Therapeutics (AAVPT) co-sponsored workshop with the United States Pharmacopeia (USP) entitled “Exploration of Developmental Approaches to Companion Animal Antimicrobials: Providing for the Unmet Therapeutic Needs of Dogs and Cats.” The workshop will immediately precede the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Annual Infectious Disease Society of America (IDSA) meeting, held in Washington DC. The two-day AAVPT/USP workshop will focus on alternative approaches to data development supporting new labeling indications consistent with the therapeutic needs of companion animal medicine.
Dr. Ambrose, Director of ICPD, will present a lecture as well as take part in a roundtable discussion at the workshop. The lecture will emphasize how pharmacokinetic and pharmacodynamic (PK-PD) analyses are a critical component for the dosage selection of antimicrobials. The roundtable discussion will focus on alternative approaches to developing data. Panelists for the roundtable include members from Academia, Industry, and the FDA.
The use of antimicrobial agents in animals has gained increased attention during the past several years. According to Dr. Ambrose, “Veterinary medicine’s acceptance of PK-PD as a critical component of dosage selection for antimicrobials is well-behind that of human medicine.” Recent work done by the Clinical Laboratory Standards Institute/Veterinary Antimicrobial Susceptibility Testing Subcommittee (CLSI/VAST) has supported the importance of using PK PD in dose-selection decisions. “Our science is being applied to other types of patients,” comments
Dr. Ambrose, “which is an important step to support CLSI/VAST recommendations.”
The ICPD serves as a center for translational science collaboration to the world. We help pharmaceutical and biotechnology companies develop more effective and safer drugs through advanced methods of pharmacokinetic and pharmacodynamic system analysis. Our general contact information is as follows:
Telephone: (518) 429-2600
Info@ICPD.com